Study reinforces need for contraception in women taking fingolimod

Nature Reviews Neurology

Volumn 10, Issue 3, 2014, Pages 125-

  Jones, Bryony ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD;

CONGENITAL HEART DISEASE; CONTRACEPTION; DRUG SAFETY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LIVE BIRTH; MULTIPLE SCLEROSIS; NONHUMAN; NOTE; PREGNANCY; PREGNANCY TERMINATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SPONTANEOUS ABORTION; TERATOGENICITY;

EID: 84895929584     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.22     Document Type: Note

References (1)

1. Karlsson, G. et al. Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology doi:10.1212/WNL. 0000000000000137